APO RESEARCH · REPORT
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis
Selected research
Market Structure
Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis include Echosens, Mindray, Hisky Med and Eieling Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market size, projected growth trends, production technologies, key applications, and end-use industries.
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Segment by Company
Echosens
Mindray
Hisky Med
Eieling Technology
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Segment by Type
Transient Elastography
Acoustic radiation force impulse (ARFI) Imaging
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Segment by Application
Hospitals
Imaging Centers
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Transient Elastography
- Acoustic radiation force impulse (ARFI) Imaging
Applications
- Hospitals
- Imaging Centers
Companies covered
- Echosens
- Mindray
- Hisky Med
- Eieling Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Dynamics
- 2.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Trends
- 2.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Drivers
- 2.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Opportunities and Challenges
- 2.4 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Restraints
3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market by Manufacturers
- 3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Manufacturers (2021-2026)
- 3.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Manufacturers (2021-2026)
- 3.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Manufacturers, Product Type & Application
- 3.7 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Players Market Share by Revenue in 2025
- 3.8.3 2025 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Tier 1, Tier 2, and Tier 3
4 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market by Type
- 4.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Type Introduction
- 4.1.1 Transient Elastography
- 4.1.2 Acoustic radiation force impulse (ARFI) Imaging
- 4.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Type
- 4.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Type (2021-2032)
- 4.2.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Type (2021-2032)
- 4.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Type
- 4.3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Type (2021-2032)
- 4.3.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Type (2021-2032)
5 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market by Application
- 5.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Imaging Centers
- 5.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application
- 5.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application (2021-2032)
- 5.2.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Application (2021-2032)
- 5.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Application
- 5.3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Application (2021-2032)
- 5.3.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Application (2021-2032)
6 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region
- 6.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region (2021-2032)
- 6.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region (2021-2026)
- 6.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region
- 7.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region
- 7.1.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region (2021-2026)
- 7.1.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region (2027-2032)
- 7.1.4 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (2021-2032)
- 7.2.2 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (2021-2032)
- 7.3.2 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Echosens
- 8.1.1 Echosens Company Information
- 8.1.2 Echosens Business Overview
- 8.1.3 Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
- 8.1.5 Echosens Recent Developments
- 8.2 Mindray
- 8.2.1 Mindray Company Information
- 8.2.2 Mindray Business Overview
- 8.2.3 Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
- 8.2.5 Mindray Recent Developments
- 8.3 Hisky Med
- 8.3.1 Hisky Med Company Information
- 8.3.2 Hisky Med Business Overview
- 8.3.3 Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
- 8.3.5 Hisky Med Recent Developments
- 8.4 Eieling Technology
- 8.4.1 Eieling Technology Company Information
- 8.4.2 Eieling Technology Business Overview
- 8.4.3 Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
- 8.4.5 Eieling Technology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Value Chain Analysis
- 9.1.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Production Mode & Process
- 9.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Distributors
- 9.2.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst